Citation Impact
Citing Papers
De novo protein synthesis is required for the activation-induced cytidine deaminase function in class-switch recombination
2003 StandoutNobel
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
2021 StandoutScienceNobel
A metabolic labeling approach toward proteomic analysis of mucin-type O-linked glycosylation
2003 StandoutNobel
Selective blockade of inhibitory Fcγ receptor enables human dendritic cell maturation with IL-12p70 production and immunity to antibody-coated tumor cells
2005 StandoutNobel
Uracil DNA Glycosylase Activity Is Dispensable for Immunoglobulin Class Switch
2004 StandoutScienceNobel
AID Enzyme-Induced Hypermutation in an Actively Transcribed Gene in Fibroblasts
2002 StandoutScienceNobel
Computational design of soluble and functional membrane protein analogues
2024 StandoutNatureNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
In vivo maturation and migration of dendritic cells
2001
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
2009 StandoutNature
Glycosylation: Heterogeneity and the 3D Structure of Proteins
1997
The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the Cytosol
1996 Standout
Human Antibody Effector Function
1992
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019 StandoutNatureNobel
Identification of disialic acid-containing glycoproteins in mouse serum: a novel modification of immunoglobulin light chains, vitronectin, and plasminogen
2006
Crystal structure of the human β2 adrenergic G-protein-coupled receptor
2007 StandoutNatureNobel
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Phagocytosis of apoptotic cells in homeostasis
2015
IRF3 Mediates a TLR3/TLR4-Specific Antiviral Gene Program
2002
The AID enzyme induces class switch recombination in fibroblasts
2002 StandoutNatureNobel
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein
2021
CCR4 as a novel molecular target for immunotherapy of cancer
2006
Natural Killer Cells: From No Receptors to Too Many
1997
Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction
1996 StandoutNature
Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part I)
1994
Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells.
1996
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
2012 Standout
Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson’s disease and dementia with Lewy bodies
2015
Human antibody–Fc receptor interactions illuminated by crystal structures
2004
The CD19/CR2/TAPA-1 Complex of B Lymphocytes: Linking Natural to Acquired Immunity
1995
Building Antibodies from their Genes
1992 StandoutNobel
Loss of splice consensus signal is responsible for the removal of the entire CH1 domain of the functional camel IGG2A heavy-chain antibodies11This work was supported by the VLIR, VIB and FGWO.
1999
Identification of Lps2 as a key transducer of MyD88-independent TIR signalling
2003 StandoutNatureNobel
Cancer-related inflammation
2008 StandoutNature
Programmed cell removal: a new obstacle in the road to developing cancer
2011
Complement recruitment using bispecific diabodies
1997 StandoutNobel
Cytomegalovirus selectively blocks antigen processing and presentation of its immediate–early gene product
1996 Nature
Programmed Cell Death in Animal Development and Disease
2011
Negative regulation of activation-induced cytidine deaminase in B cells
2006 StandoutNobel
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer
1997 StandoutNobel
Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium
1996 StandoutNobel
Refined Structure of an Intact IgG2a Monoclonal Antibody,
1997
Binding of Hepatitis C Virus to CD81
1998 StandoutScienceNobel
Nonimmunoglobulin target loci of activation-induced cytidine deaminase (AID) share unique features with immunoglobulin genes
2012 StandoutNobel
Identification of DNA cleavage- and recombination-specific hnRNP cofactors for activation-induced cytidine deaminase
2015 StandoutNobel
Programmed assembly of 3-dimensional microtissues with defined cellular connectivity
2009 StandoutNobel
Exosomes in Parkinson’s Disease: Current Perspectives and Future Challenges
2019
The N-terminal end of the CH2 domain of chimeric human IgG1 anti-HLA-DR is necessary for C1q, Fc gamma RI and Fc gamma RIII binding.
1995
Molecular Mechanism of Class Switch Recombination: Linkage with Somatic Hypermutation
2002 StandoutNobel
Network of dendritic cells within the muscular layer of the mouse intestine
2005 StandoutNobel
AID-induced decrease in topoisomerase 1 induces DNA structural alteration and DNA cleavage for class switch recombination
2009 StandoutNobel
The C-terminal region of activation-induced cytidine deaminase is responsible for a recombination function other than DNA cleavage in class switch recombination
2009 StandoutNobel
Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils
1997 StandoutNobel
Further evidence for involvement of a noncanonical function of uracil DNA glycosylase in class switch recombination
2009 StandoutNobel
The biology , function , and biomedical applications of exosomes
2020 StandoutScience
IgG Fc Receptors
2001
"Diabodies": small bivalent and bispecific antibody fragments.
1993 StandoutNobel
Differential regulation of S-region hypermutation and class-switch recombination by noncanonical functions of uracil DNA glycosylase
2014 StandoutNobel
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
DNA cleavage in immunoglobulin somatic hypermutation depends onde novoprotein synthesis but not on uracil DNA glycosylase
2005 StandoutNobel
Activation of naïve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus-associated B lymphocyte disorders
2005 StandoutNobel
Histone chaperone Spt6 is required for class switch recombination but not somatic hypermutation
2011 StandoutNobel
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Polysialic acid governs T-cell development by regulating progenitor access to the thymus
2009 StandoutNobel
Histone3 lysine4 trimethylation regulated by the facilitates chromatin transcription complex is critical for DNA cleavage in class switch recombination
2010 StandoutNobel
APE1 is dispensable for S-region cleavage but required for its repair in class switch recombination
2014 StandoutNobel
Immune Therapy for Cancer
2008
THE UBIQUITIN SYSTEM
1998 StandoutNobel
Activation-induced cytidine deaminase shuttles between nucleus and cytoplasm like apolipoprotein B mRNA editing catalytic polypeptide 1
2004 StandoutNobel
Extracellular microRNAs in human circulation are associated with miRISC complexes that are accessible to anti-AGO2 antibody and can bind target mimic oligonucleotides
2020 StandoutNobel
De novo protein synthesis is required for activation-induced cytidine deaminase-dependent DNA cleavage in immunoglobulin class switch recombination
2004 StandoutNobel
RNA-editing cytidine deaminase Apobec-1 is unable to induce somatic hypermutation in mammalian cells
2003 StandoutNobel
Works of John D. Pound being referenced
Microenvironmental influences of apoptosis in vivo and in vitro
2010
Engagement of CD40 lowers the threshold for activation of resting B cells via antigen receptor
1993
Retargeting serum immunoglobulin with bispecific diabodies
1997 StandoutNobel
Purification of human blood eosinophils by negative selection using immunomagnetic beads
1989
Fortifying B cells with CD154: an engaging tale of many hues
2000
Apoptotic human cells inhibit migration of granulocytes via release of lactoferrin
2008
Modulation of MHC antigen expression by viruses and oncogenes
1991
Molecular definition of interaction sites on human IgG for Fc receptors (huFcγR)
1990
IgG‐Fc‐mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation
1998
Cell death in the neighbourhood: direct microenvironmental effects of apoptosis in normal and neoplastic tissues
2010
Signals sustaining human immunoglobulin V gene hypermutation in isolated germinal centre B cells
2000
Quantification of human urinary exosomes by nanoparticle tracking analysis
2013
Human Fc gamma RI and Fc gamma RII interact with distinct but overlapping sites on human IgG.
1991
Enhanced Apoptotic Cell Clearance Capacity and B Cell Survival Factor Production by IL-10-Activated Macrophages: Implications for Burkitt’s Lymphoma
2005
Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc gamma receptor I and influence the synthesis of its oligosaccharide chains.
1996
CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis
2008
Oligosaccharide‐protein interactions in IgG can modulate recognition by Fcγ receptors
1995